Clinical Trial Update: Pentoxifylline in Treatment of Patients With Nonalcoholic Steatohepatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pentoxifylline for nonalcoholic steatohepatitis has completed, according to the trial registry update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Al-Azhar University | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 3 | Status: COMPLETED